Items where Author is "Tornai, David"

Article

Janka, T. and Tornai, Tamás and Borbély, B. and Tornai, David and Altorjay, István and Papp, Mária and Vitalis, Zsuzsanna (2019) Deleterious effect of proton pump inhibitors on the disease course of cirrhosis. European Journal of Gastroenterology and Hepatology. ISSN 0954-691X (print), 1473-5687 (online) (In Press)

Tornai, Tamás and Tornai, David and Sipeki, Nora and Tornai, István and Alsulaimani, Rayan and Fechner, Kai and Roggenbuck, Dirk and Norman, Gary L. and Veres, Gábor and Pár, Gabriella and Pár, Alajos and Szalay, Ferenc and Lakatos, Péter László and Antal-Szalmás, Péter and Papp, Mária (2018) Loss of tolerance to gut immunity protein, glycoprotein 2 (GP2) is associated with progressive disease course in primary sclerosing cholangitis. SCIENTIFIC REPORTS, 8 (1). pp. 1-11. ISSN 2045-2322

Dinya, Tamás and Tornai, Tamás and Vitalis, Zsuzsanna and Tornai, István and Balogh, Boglárka and Tornai, David and Antal-Szalmás, Péter and Sümegi, Andrea and Andrikovics, Hajnalka and Bors, Andras and Tordai, Attila and Papp, Mária (2018) Functional polymorphisms of innate immunity receptors are not risk factors for the non-SBP type bacterial infections in cirrhosis. LIVER INTERNATIONAL. ISSN 1478-3223 (Submitted)

Tornai, Tamás and Palyu, Eszter and Vitalis, Zsuzsanna and Tornai, István and Tornai, David and Antal-Szalmás, Péter and Norman, Gary L. and Shums, Zakera and Veres, Gábor and Dezsőfi, Antal and Pár, Gabriella and Pár, Alajos and Orosz, Péter and Szalay, Ferenc and Lakatos, Péter László and Papp, Mária (2017) Gut barrier failure biomarkers are associated with poor disease outcome in patients with primary sclerosing cholangitis. World Journal of Gastroenterology, 23 (29). pp. 5412-5421. ISSN 1007-9327 (print), 2219-2840 (online)

Földi, Ildikó and Tornai, Tamás and Tornai, David and Sipeki, Nora and Vitalis, Zsuzsanna and Tornai, István and Dinya, Tamás and Antal-Szalmás, Péter and Papp, Mária (2017) Lectin-complement pathway molecules are decreased in patients with cirrhosis and constitute the risk of bacterial infections. LIVER INTERNATIONAL, 37 (7). pp. 1023-1031. ISSN 1478-3223 (Submitted)

Tornai, Tamas and Vitalis, Zsuzsanna and Sipeki, Nora and Dinya, Tamas and Tornai, David and Antal-Szalmas, Peter and Karanyi, Zsolt and Tornai, Istvan and Papp, Maria (2016) Macrophage activation marker, soluble CD163 is an independent predictor of short-term mortality in patients with cirrhosis and bacterial infection. Liver International. ISSN 1478-3223 (In Press)